The Proposed Drug Conditional Approval Pathway and Responses From Cancer Survivors

Key Points

• The study aims to evaluate cancer survivors' understanding of the FDA's conditional drug approval pathway and their responses to it.
• Conducted a survey among cancer survivors and current patients
• Assessed knowledge of the conditional approval pathway
• Gathered feedback on the proposed approval process
• A significant portion of respondents had limited understanding of the proposed pathway
• Many expressed concerns about the safety and efficacy of drugs approved conditionally
• Responses varied based on demographic factors such as age and treatment history